Redevelopment of Space for Booming Life Sciences Firms
December 14, 2020
As the race for a vaccine or widely available treatment for COVID-19 kicks into high gear, many life sciences firms are looking to ramp up their production capacity — for this and future public health crises. With this anticipated growth in production volume comes the need for more lab space. But when looking for space to expand, life sciences firms may need to look beyond space specifically built for life sciences and identify sites that have been redeveloped into lab space.
Developers are taking note that some markets that have the assets of a life science cluster — such as proximity to large medical and university campuses and quality-of-life benefits for a growing workforce — haven’t yet actualized into a cluster, and they have an opportunity to seize the moment. Such developers are building new offices and research facilities and converting old structures into labs. Economic development commissions also have the opportunity to partner with developers to help bring the pieces together to draw life sciences companies and create these new clusters.
